The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Forbes
Quarterly earnings season may be winding down, but the real earnings season – annual 10-K filing season – is ramping up. Quarterly earnings reports provide investors with limited and often misleading data. In “ Core Earnings: New Data and Evidence core earnings This report highlights one firm that looks more profitable than its GAAP results indicate and demonstrates how GAAP net income growth doesn’t lead to increased market cap. Footnotes Help Us Find Undervalued Companies After analyzing its 65 page 2019 10-K last week, Kimberly-Clark (KMB)[1] looks even more profitable than GAAP earnings suggest. Here’s why: the following hidden unusual expenses cause GAAP earnings to understate core earnings: Each of these charges are related to KMB’s 2018 Global Restructuring Program. In addition, I found the following reported non-operating expense: The company reported $2.2 billion in GAAP net income, but my adjustments show that they earned $2.5 billion in net operating profit after-tax
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.MarketBeat
- Should You Pick Abbott Stock At $105 After An Upbeat Q1? [Forbes]Forbes
- Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario [Seeking Alpha]Seeking Alpha
- D-dimer Testing Market to hit USD 2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website